12,372 trials
Hypoglycemia · Diabetes Mellitus, Type 1
Primary: Time to Plasma Glucose Recovery — 10; 40; 12 minutes — p=<0.001
Pulmonary Arterial Hypertension
Primary: Change in Exercise Capacity at Month 12 — 22.0 meters
Hypoglycemia
Primary: Time to Plasma Glucose Recovery — 10.00; 30.00; 10.00 minutes — p=<0.001
Cancer and Chemotherapy Related Anemia
Primary: Percentage of Participants With a Decrease in Hemoglobin ≥ 0.5 g/dL From Week 3 to Week 18 — 42; 60 Participants — p=0.0143
Gastric Cancer · Gastroesophageal Junction Cancer
Primary: Overall Survival — 6.93; 7.36 Months — p=0.8596
Breast Cancer · Neutropenia
Primary: Duration in Days of Grade 4 Neutropenia in Chemotherapy Cycle 1 — 0.2; 0.2 days
Anemia; Hemodialysis Dependent Chronic Kidney Disease
Primary: Mean Hb Level of Week 20 and Week 24 — 10.75 g/dL
Tobacco Use Disorder · Smoking Cessation
Primary: Emotional Reactivity By Pharmacotherapy — 66.6; 64.7; 65.6; 70.9 microvolts
Heart Failure With Reduced Ejection Fraction (HFrEF)
Primary: Change From Baseline in Kansas-City Cardiomyopathy Questionnaire-Total Symptom Score (KCCQ-TSS) at Week 16 (Higher Scores Represent Less HF Symptom Frequency and…
Attention Deficit Disorder · Attention Deficit Hyperactivity Disorder
Primary: Change From Baseline in ADHD Investigator Symptom Rating Scale (AISRS) — -10.1; -9.73; -6.98 score on a scale — p==0.0193
Dry Eye
Primary: Change in Fluorescein Corneal Staining (FCS) Score From Baseline — -3.3; -2.0; -2.9 score on a scale — p=<0.001
Localized Extraskeletal Ewing Sarcoma · Peripheral Primitive Neuroectodermal Tumor of Bone · Peripheral Primitive Neuroectodermal Tumor of Soft Tissues
Primary: Event-Free Survival — 77.64; 78.79 Percent Probability
Acne Vulgaris
Primary: Mean Percent Change in the Number of Inflamed Lesions — -39.4; -40.0; -35.1 percent change
Chronic Graft Versus Host Disease
Primary: Primary Analysis: Response Rate at 48 Weeks — 41.1; 36.7 percentage of participants — p=0.5384
Esophageal Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma · Stage IB Esophageal Cancer AJCC v7
Primary: Disease-free Survival (DFS) — 19.6; 14.2 months — p=0.85